Login required. Manage anytime from Account → Subscriptions.
on orders over $200
plain and unbranded packaging
256-bit SSL
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥ & 99% |
| Form | Lyophilized powder |
-20°C 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | IGF-1 1mg |
|---|---|
| Lot # | IG0001 |
| Labeled | 1mg |
| Actual | 1.05mg |
| Tested | Jul 24, 2026 |
Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats
1992
DOI: 10.1042/bj2820091
PMID: 1371669
· Tomas FM, Knowles SE, Owens PC et al.
Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection
1996
DOI: 10.1677/joe.0.1500077
PMID: 8708565
· Tomas FM, Lemmey AB, Read LC, Ballard FJ
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms
2002
DOI: 10.1677/joe.0.1750019
PMID: 12379487
· Mohan S, Baylink DJ
Lumera BioLabs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Not a researcher? Exit